000000736 001__ 736
000000736 005__ 20231128134553.0
000000736 0247_ $$2DOI$$a10.6083/M4H9936X
000000736 037__ $$aETD
000000736 245__ $$aNovel cell therapies for liver disease and type 1 diabetes
000000736 269__ $$a2012
000000736 336__ $$aDissertation
000000736 502__ $$bPh.D.
000000736 540__ $$fCC BY
000000736 542__ $$fIn copyright - single owner
000000736 650__ $$aLiver Diseases$$021588
000000736 650__ $$aPancreas$$023506
000000736 650__ $$aLiver$$021580
000000736 650__ $$aPancreatic Diseases$$023509
000000736 650__ $$aTransplantation$$027278
000000736 6531_ $$adiseases
000000736 6531_ $$adiabetes
000000736 6531_ $$acell nuclei
000000736 6531_ $$atissue therapy
000000736 6531_ $$adiabetes mellitus  type 1
000000736 6531_ $$acellular therapy
000000736 6531_ $$anuclear reprogramming
000000736 691__ $$aSchool of Medicine$$041369
000000736 692__ $$aDepartment of Molecular and Medical Genetics$$041428
000000736 7001_ $$aHickey, Raymond D.
000000736 8564_ $$9731de66f-06ff-4391-a142-f05b14d132c6$$s3365019$$uhttps://digitalcollections.ohsu.edu/record/736/files/739_etd.pdf
000000736 905__ $$a/rest/prod/dr/26/xx/39/dr26xx39d
000000736 909CO $$ooai:digitalcollections.ohsu.edu:736$$pstudent-work
000000736 980__ $$aTheses and Dissertations